China is no longer just a biotech market. It is increasingly a source of licensable innovation for global pharma.

Sanofi’s up-to-$1.53B rovadicitinib deal is the latest signal — and part of a much bigger shift in where drug innovation begins.

https://biotech.industryexaminer.com/sanofi-china-biotech-licensing-global-innovation/

#Biotech #Pharma #ChinaBiotech #DrugDevelopment #BiotechNews #TechNews

FDA lifted the clinical hold on Intellia’s MAGNITUDE Phase 3 (ATTR-CM). The headline says “resume.”

The real story: a safety reset—tighter selection + heavier liver monitoring + explicit mitigation steps.

Our take: “conditional confidence” is the new normal for one-and-done biology.

https://biotech.industryexaminer.com/crispr-safety-reset-intellia-fda-hold-lift/

#CRISPR #Biotech #ClinicalTrials #BiotechNews #technew

Scientists have achieved a ground-breaking milestone in the fight against HIV by developing a CRISPR-based therapy that removes HIV DNA from infected human cells and prevents the virus from returning. This revolutionary approach targets the viral genetic material directly, effectively erasing HIV from the cell’s genome and halting its ability to replicate.

In laboratory studies, treated cells showed no signs of viral rebound, offering a potential pathway toward a permanent cure for HIV, a disease that has affected millions globally. Unlike traditional antiretroviral therapies, which only suppress the virus, this CRISPR therapy tackles the root cause, providing hope for a one-time treatment with long-lasting effects.

Researchers emphasise that while early results are promising, further studies and clinical trials are required to ensure safety and efficacy in humans. If successful, this therapy could transform HIV treatment and bring the world closer to ending the HIV/AIDS epidemic once and for all.

HIV / AIDS & Global Health
#HIV #AIDS #EndHIV #HIVCure #HIVResearch #GlobalHealth #PublicHealth #HealthInnovation #MedicalBreakthrough

CRISPR & Gene Editing
#CRISPR #GeneEditing #Genomics #GenomeTherapy #Biotech #MolecularBiology #GeneticEngineering #BioTechNews #LabLife

Science & Discovery
#ScienceNews #MedicalResearch #ScientificBreakthrough #HealthTech #FutureOfMedicine #LifeSciences #ResearchMatters #Innovation

Awareness & Advocacy
#HIVAwareness #HealthEquity #WorldHealth #InfectiousDiseases #CommunityHealth #HealthForAll

Hope & Progress
#CureHIV #EndTheEpidemic #HopeInScience #NextGenMedicine #OneStepCloser #HealingThroughScience

Japan’s scientists team is pioneering a USAG‑1–blocking antibody that has successfully triggered new tooth growth in animals and is now in early human safety trials. If proven safe and effective, tooth regeneration medicine could be just a few years away—potentially transforming dental care forever.

#HealthNews #DentalHealth #PharmaNews #BreakingNews #BiotechNews #MedicalBreakthrough